Sleep Apnea: Causes, Symptoms and Treatment

Submitted by webmaster on Wed, 10/17/2018 - 15:05

Sleep apnea  is a sleep disorder causing pauses in respiration during sleep, and each episode results in missing of one or more breaths, and such apneas occur recurrently throughout sleep period. The respiratory control mechanism is less effective during sleep and brief periods of apnea occur in normal sleeping adults. During sleep there is decreased sensitivity to low PCO2 (Partial pressure of Carbon dioxide). Because of this decreased sensitivity, PCO2 may fall during sleep which may lead to apnea.

Medical Visa Requirements for India

Submitted by webmaster on Wed, 10/17/2018 - 15:00

Medical Travel or Medical Tourism is the technical term used to refer to the rapidly growing, modern practice of people traveling from one country to another  for obtaining their medical treatments or for any type of health care services. In a critical way, it also refers to the  practice of people traveling with the intent of getting health-care services or health care specialists traveling worldwide to offer their services.

Truncus Arteriosus: Causes, Symptoms, Diagnosis and Treatment

Submitted by webmaster on Wed, 10/17/2018 - 14:54

Truncus arteriosus is actually a heart defect which leads to severe problems the circulatory system. It is a rare type of heart disease, and it is congenital in which a large blood vessel leads out of the left and right ventricles, instead of the normal two blood vessels, that is, one  pulmonary artery and aorta. The two lower chambers of the heart also miss a portion of the wall which separates them.

Dabigatran and Warfarin

Submitted by webmaster on Wed, 10/17/2018 - 14:39

Dabigatran is an anti-coagulant medication that is FDA approved. With the generic name dabigatran etexilate mesylate, the drug is marketed under the trade name Pradaxa and manufactured by Boehringer Ingelheim. Dabigatran seems to be a promising drug and a suitable replacement for Warfarin with convenience and more speedy therapeutic action than the later. Dabigatran is a direct thrombin inhibitor. It has a stable and very predictable pharmacokinetics and does not require routine monitoring.